This is what we know--colorectal cancer screening works. Despite this, screening rates remain problematic. According to the Centers for Disease Control and Prevention, about one in three adults ages 50 to 75, haven't been tested for colorectal cancer as recommended by the United States Preventive Services Task Force.
In a recent commentary published in the Journal of Patient Safety, Stephen Swensen, a radiologist at Mayo Clinic, and colleagues make an "Appeal for Safe and Appropriate Imaging of Children."
Clearly radiology practices and imaging facilities still face security and privacy challenges.
Breast cancer screening and its effect on cancer mortality rates, as well as the harms associated with overdiagnosis and false positives, was in the news yet again this past week as a study in the journal BMJ showed that mammography screening can significantly cut mortality rates from the disease. But in a commentary accompanying the article, the authors suggested that the question remains whether the benefits of mammography outweigh its harms, a question that should be the subject of a discussion between doctors and their patients, they say.
That begs another question: Are doctors having the right kind of conversation with their patients about breast cancer screening?
Considering the amount of attention that has been placed on issues relating to medical radiation and exposure over the last few years, the fact that there are still several states that don't have any licensing standards on the books for radiologic technologists is rather perplexing
Several weeks ago when the Medicare Evidence Development and Coverage Advisory Committee voted not to support Medicare coverage for CT lung cancer screening, several panel members suggested that providers might be better off investing more money into smoking cessation than CT screening. There also have been arguments raised that lung cancer screening programs can complicate efforts to get smokers to quit smoking.
Last week, a pair of articles published in the mainstream press illustrated the sense of confusion that healthcare consumers must feel about cancer screening tests.